Your browser doesn't support javascript.
loading
A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors.
Khaki, Ali Raza; Li, Ang; Diamantopoulos, Leonidas N; Miller, Natalie J; Carril-Ajuria, Lucia; Castellano, Daniel; De Kouchkovsky, Ivan; Koshkin, Vadim; Park, Joseph; Alva, Ajjai; Bilen, Mehmet A; Stewart, Tyler; Santos, Victor; Agarwal, Neeraj; Jain, Jayanshu; Zakharia, Yousef; Morales-Barrera, Rafael; Devitt, Michael; Nelson, Ariel; Hoimes, Christopher J; Shreck, Evan; Gartrell, Benjamin A; Sankin, Alex; Tripathi, Abhishek; Zakopoulou, Roubini; Bamias, Aristotelis; Rodriguez-Vida, Alejo; Drakaki, Alexandra; Liu, Sandy; Kumar, Vivek; Lythgoe, Mark P; Pinato, David J; Murgic, Jure; Fröbe, Ana; Joshi, Monika; Isaacsson Velho, Pedro; Hahn, Noah; Alonso Buznego, Lucia; Duran, Ignacio; Moses, Marcus; Barata, Pedro; Galsky, Matthew D; Sonpavde, Guru; Yu, Evan Y; Shankaran, Veena; Lyman, Gary H; Grivas, Petros.
Afiliação
  • Khaki AR; Division of Medical Oncology, Department of Medicine, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA.
  • Li A; Section of Hematology/Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Diamantopoulos LN; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • Miller NJ; Department of Medicine, University of Washington, Seattle, WA, USA.
  • Carril-Ajuria L; Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Castellano D; Hospital Universitario 12 de Octubre, Madrid, Spain.
  • De Kouchkovsky I; Division of Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Koshkin V; Division of Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Park J; Division of Oncology, Department of Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Alva A; Division of Oncology, Department of Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Bilen MA; Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Stewart T; Division of Oncology, Department of Medicine, University of California, San Diego, La Jolla, CA, USA.
  • Santos V; Division of Oncology, Department of Medicine, University of Utah, Salt Lake City, UT, USA.
  • Agarwal N; Division of Oncology, Department of Medicine, University of Utah, Salt Lake City, UT, USA.
  • Jain J; Department of Medicine, University of Iowa, Iowa City, IA, USA.
  • Zakharia Y; Division of Oncology, Department of Medicine, University of Iowa, Iowa City, IA, USA.
  • Morales-Barrera R; Vall d'Hebron Institute of Oncology, Vall d' Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Devitt M; Division of Hematology/Oncology, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA, USA.
  • Nelson A; Division of Medical Oncology, Seidman Cancer Center at Case Comprehensive Cancer Center, Cleveland, OH, USA; Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Hoimes CJ; Division of Medical Oncology, Seidman Cancer Center at Case Comprehensive Cancer Center, Cleveland, OH, USA; Division of Medical Oncology, Duke University, Durham, NC, USA.
  • Shreck E; Departments of Medical Oncology and Urology, Montefiore Medical Center, Bronx, NY, USA.
  • Gartrell BA; Departments of Medical Oncology and Urology, Montefiore Medical Center, Bronx, NY, USA.
  • Sankin A; Departments of Medical Oncology and Urology, Montefiore Medical Center, Bronx, NY, USA.
  • Tripathi A; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Zakopoulou R; Department of Clinical Therapeutics, Alexandra General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Bamias A; 2nd Propaedeutic Department of Internal Medicine, ATTIKON University Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Rodriguez-Vida A; Medical Oncology Department, Hospital del Mar Research Institute, Barcelona, Spain.
  • Drakaki A; Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Liu S; Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Kumar V; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Lythgoe MP; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Pinato DJ; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Murgic J; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, School of Dental Medicine, Zagreb, Croatia.
  • Fröbe A; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, School of Dental Medicine, Zagreb, Croatia.
  • Joshi M; Division of Hematology/Oncology, Department of Medicine, Penn State Cancer Institute, Hershey, PA, USA.
  • Isaacsson Velho P; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
  • Hahn N; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
  • Alonso Buznego L; Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain.
  • Duran I; Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain.
  • Moses M; Department of Medicine, Section of Hematology/Oncology, Tulane University, New Orleans, LA, USA.
  • Barata P; Department of Medicine, Section of Hematology/Oncology, Tulane University, New Orleans, LA, USA.
  • Galsky MD; Division of Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Sonpavde G; Genitourinary Oncology Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Yu EY; Division of Medical Oncology, Department of Medicine, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA.
  • Shankaran V; Division of Medical Oncology, Department of Medicine, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA.
  • Lyman GH; Division of Medical Oncology, Department of Medicine, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA.
  • Grivas P; Division of Medical Oncology, Department of Medicine, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. Electronic address: pgrivas@uw.edu.
Eur Urol Oncol ; 4(3): 464-472, 2021 06.
Article em En | MEDLINE | ID: mdl-33423945
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans Idioma: En Revista: Eur Urol Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans Idioma: En Revista: Eur Urol Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos